How Safe Are the Nanoparticles in Moderna’s Vaccine?

I recently interviewed Judy Mikovits, Ph.D., a cellular and molecular biologist, and she agreed that LNPs can enter the brain can contribute to pathologic neuroinflammation, possibly leading to adverse effects like multiple sclerosis or ALS. Additionally, these LNPs carrying the mRNA last for long periods of time, forcing your cells to continuously produce the SARS-CoV-2 spike protein. I encourage you to review my article and interview with Judy.

The mRNA vaccine triggers your body to produce antibodies against the SARS-CoV-2 spike protein, and spike proteins in turn contain syncytin-homologous proteins that are essential for various functions in your body, including the formation of the placenta in pregnant women.

“Syncytin is the name given to the endogenous gamma retrovirus envelope,” Mikovits said, “and we know if it’s expressed overtly in the body in different places … for instance, in the brain, where these lipid nanoparticles will go, then you’ve got multiple sclerosis.” She continued:

“So the expression of that gene alone enrages microglia, literally inflames, and dysregulates the communication between the brain microglia, which are critical for clearing toxins and pathogens in the brain, and the communication with the astrocytes that dysregulates not only the immune system but the endocannabinoid system …

We’ve already seen in the clinical trials … multiple sclerosis as an adverse event, and we’re being lied to. ‘Oh, those people had that.’ No, they didn’t. And we also see myalgic encephalomyelitis, inflammation of the brain and the spinal cord.”

It’s also worth noting that Moderna has no legal rights to a key patent for its vaccine delivery system, and company executives are among those who have dumped their stock. Both Moderna and the NIH are essentially engaged in patent infringement, as a core part of the technology — the LNP technology that is part of the vaccine delivery system — belongs to a small Canadian biotech company called Arbutus.31

Indeed the vaccine has already been rolled out, but before making your decision on whether or not to receive it, be sure you’re informed about the many unanswered questions and risks surrounding it, including not only those related to LNPs but also another significant issue known as antibody‐dependent enhancement (ADE).

Dr Mercola How Safe Are the Nanoparticles in Moderna’s Vaccine?